LRRK2
LRRK2 (Leucine-rich repeat kinase 2) is an enzyme that interacts with parkin and is associated with Parkinson's disease and also Crohn's disease.
Products for LRRK2
- Cat.No. Product Name Information
-
GC74017
CC-3240
CC-3240 (compound 13) is a molecular glue degrader of CaMKK2 based on CC-8977, with the IC50 of 9 nM.
-
GC16731
CZC 54252 hydrochloride
CZC 54252 hydrochloride is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2, respectively.
-
GC16038
CZC-25146
LRRK2 inhibitor
-
GC35792
CZC-25146 hydrochloride
CZC-25146 hydrochloride is a potent LRRK2 inhibitor with IC50 values of 4.76 nM and 6.87 nM for wild-type LRRK2 and G2019S LRRK2, respectively.
-
GC64730
EB-42486
EB-42486 is a novel, potent, and highly selective G2019S-LRRK2 inhibitor (IC50 < 0.2 nM).
-
GC12121
GNE-7915
Potent and selective LRRK2 inhibitor
-
GC36171
GNE-7915 tosylate
GNE-7915 tosylate is a potent, selective and brain-penetrant inhibitor of LRRK2 with an IC50 of 9 nM.
-
GC13868
GNE-9605
LRRK2 inhibitor, brain-penetrant, potent and selective
-
GC15196
GNE0877
Potent and selective LRRK2 inhibitor
-
GC18049
GSK2578215A
LRRK2 inhibitor
-
GC13098
HG-10-102-01
LRRK2 inhibitor
-
GC12370
IKK-16 (hydrochloride)
IKK Inhibitor VII
IκB kinases (IKKs) inhibitor -
GC12180
IKK-16 (IKK Inhibitor VII)
IKK-16 (IKK Inhibitor VII) is a selective IκB kinase (IKK) inhibitor for IKK2, IKK complex and IKK1 with IC50s of 40 nM, 70 nM and 200 nM, respectively.
-
GC19205
JH-II-127
JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor, with IC50 of 6.6 nM, 2.2 nM ,47.7 nM for LRRK2-wild-type, LRRK2-G2019S, LRRK2-A2016T.
-
GC73550
JH-XII-03-02
JH-XII-03-02 is a potent and selective LRRK2 PROTAC degrader.
-
GC65390
LRRK2 inhibitor 1
LRRK2 inhibitor 1 is a potent, selective and oral LRRK2 inhibitor with an pIC50 of 6.8.
-
GC10809
LRRK2-IN-1
Leucine-rich repeat kinase 2 IN-1
A selective LRRK2 inhibitor -
GC69402
LRRK2-IN-7
LRRK2-IN-7 is an effective, selective, CNS-penetrant LRRK2 kinase inhibitor with an IC50 of 0.9 nM. The selectivity of LRRK2-IN-7 is over 1000-fold for other kinases, ion channels and CYP enzymes.
-
GC30769
MLi-2
An LRRK2 inhibitor
-
GC13850
PF-06447475
LRRK2 inhibitor
-
GC64566
PF-06454589
PF-06447475 is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively.
-
GC64506
PF-06456384 trihydrochloride
PF-06447475 trihydrochloride is a highly potent, selective, brain penetrant LRRK2 kinase inhibitor with IC50 values of 3 nM and 11 nM for WT LRRK and G2019S LRRK2, respectively.
-
GC36888
PFE-360
PF-06685360
PFE-360 (PF-06685360) is a potent, selective, brain penetrated and orally active leucine-rich repeat kinase 2 (LRRK2) inhibitor with a mean IC50 of 2.3 nM in vivo. -
GC73147
XL01126
XL01126 is a potent LRRK2 PROTAC (DC50: 14 nM (G2019S LRRK2) and 32 nM (WT LRRK2)) composed of the VHL ligand VH 101, thiol and the LRRK2 inhibitor HG-10-102-01.